The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...

Not much has changed. Diets, intermittent fasting, weight-loss surgery, and more recently, weight-loss injections continue to be marketed as solutions for shedding pounds. Achieving a healthy ...

Lizzo/Instagram Lizzo is sharing some cheeky new selfies — and some of her favorite Severance memes — as she continues her weight loss journey. On Friday, March 21, the "Truth Hurts" singer ...

Danielle Peebles, 42, underwent weight loss surgery in Turkey that led to severe complications and paralysis due to nutritional neuropathy. She lost 95 kg but faced alarming health issues on her ...

Prescription weight loss medications, including GLP-1 agonists, orlistat, and Contrave, may be effective for some people. But other lifestyle changes are still necessary for long-term success.

Credit loss provisions increased to $219M amid macroeconomic changes. Feel unsure about the market’s next move? Copy trade alerts from Matt Maley—a Wall Street veteran who consistently finds ...

Jim Banks and U.S. Sen. Todd Young, stating their “strong opposition to any efforts to increase truck weight limits.” The letter was written by commissioner Gary McDaniel, with fellow ...

("Editorial: Immigrants have helped offset St. Louis' population loss. Then came Trump." March 16.) Phyllis Jacobson St. Louis Have you ever wanted to submit a letter to the Editorial Board of the ...

Weight Loss Increases Risk of Early Death for Obese Adults Mar. 12, 2025 — New research has found for the first time that extreme weight fluctuations in obese individuals with cardiovascular ...

In a key secondary endpoint, 31.6% of people taking tirzepatide achieved at least 25% body weight loss compared to 16.1% of those receiving semaglutide, according to Lilly, which said it plans to ...

Nurix Therapeutics, Inc. (NRIX) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $0.76 per share a year ago.